Skip to main content
Erschienen in: Journal of Gastrointestinal Surgery 12/2015

01.12.2015 | Original Article

Incidence and Risk Factors Associated with Readmission After Surgical Treatment for Adrenocortical Carcinoma

verfasst von: Javier Valero-Elizondo, Yuhree Kim, Jason D. Prescott, Georgios A. Margonis, Thuy B. Tran, Lauren M. Postlewait, Shishir K. Maithel, Tracy S. Wang, Jason A. Glenn, Ioannis Hatzaras, Rivfka Shenoy, John E. Phay, Kara Keplinger, Ryan C. Fields, Linda X. Jin, Sharon M. Weber, Ahmed Salem, Jason K. Sicklick, Shady Gad, Adam C. Yopp, John C. Mansour, Quan-Yang Duh, Natalie Seiser, Carmen C. Solorzano, Colleen M. Kiernan, Konstantinos I. Votanopoulos, Edward A. Levine, George A. Poultsides, Timothy M. Pawlik

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 12/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

Adrenocortical carcinoma (ACC) is a rare disease with a poor prognosis. Given the lack of data on readmission after resection of ACC, the objective of the current study was to define the incidence of readmission, as well as identify risk factors associated with readmission among patients with ACC who underwent surgical resection.

Methods

Two hundred nine patients who underwent resection of ACC between January 1993 and December 2014 at 1 of 13 major centers in the USA were identified. Demographic and clinicopathological data were collected and analyzed relative to readmission.

Results

Median patient age was 52 years, and 62 % of the patients were female. Median tumor size was 12 cm, and the majority of patients had an American Society of Anesthesiologists (ASA) class of 3–4 (n = 85, 56 %). The overall incidence of readmission within 90 days from surgery was 18 % (n = 38). Factors associated with readmission included high ASA class (odds ratio (OR), 4.88 (95 % confidence interval (CI), 1.75–13.61); P = 0.002), metastatic disease on presentation (OR, 2.98 (95 % CI, 1.37–6.46); P = 0.006), EBL (>700 mL: OR, 2.75 (95 % CI, 1.16–6.51); P = 0.02), complication (OR, 1.91 (95 % CI, 1.20–3.05); P = 0.007), and prolonged length of stay (LOS; ≥9 days: OR, 4.12 (95 % CI, 1.88–9.01); P < 0.001). On multivariate logistic regression, a high ASA class (OR, 4.01 (95 % CI, 1.44–11.17); P = 0.008) and metastatic disease on presentation (OR, 3.44 (95 % CI, 1.34–8.84); P = 0.01) remained independently associated with higher odds of readmission.

Conclusion

Readmission following surgery for ACC was common as one in five patients experienced a readmission. Patients with a high ASA class and metastatic disease on presentation were over four and three times more likely to be readmitted after surgical treatment for ACC, respectively.
Literatur
1.
Zurück zum Zitat Abiven G, Coste J, Groussin L, Anract P, Tissier F, Legmann P, Dousset B, Bertagna X, Bertherat J. Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients. The Journal of Clinical Endocrinology and Metabolism 2006;91(7):2650–2655.CrossRefPubMed Abiven G, Coste J, Groussin L, Anract P, Tissier F, Legmann P, Dousset B, Bertagna X, Bertherat J. Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients. The Journal of Clinical Endocrinology and Metabolism 2006;91(7):2650–2655.CrossRefPubMed
2.
Zurück zum Zitat Icard P, Goudet P, Charpenay C, Andreassian B, Carnaille B, Chapuis Y, Cougard P, Henry JF, Proye C. Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group. World Journal of Surgery 2001;25(7):891–897.CrossRefPubMed Icard P, Goudet P, Charpenay C, Andreassian B, Carnaille B, Chapuis Y, Cougard P, Henry JF, Proye C. Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group. World Journal of Surgery 2001;25(7):891–897.CrossRefPubMed
3.
Zurück zum Zitat Venkatesh S, Hickey RC, Sellin RV, Fernandez JF, Samaan NA. Adrenal cortical carcinoma. Cancer 1989;64(3):765–769.CrossRefPubMed Venkatesh S, Hickey RC, Sellin RV, Fernandez JF, Samaan NA. Adrenal cortical carcinoma. Cancer 1989;64(3):765–769.CrossRefPubMed
4.
Zurück zum Zitat Kasperlik-Zaluska AA, Migdalska BM, Zgliczynski S, Makowska AM. Adrenocortical carcinoma. A clinical study and treatment results of 52 patients. Cancer 1995;75(10):2587–2591.CrossRefPubMed Kasperlik-Zaluska AA, Migdalska BM, Zgliczynski S, Makowska AM. Adrenocortical carcinoma. A clinical study and treatment results of 52 patients. Cancer 1995;75(10):2587–2591.CrossRefPubMed
5.
Zurück zum Zitat Didolkar MS, Bescher RA, Elias EG, Moore RH. Natural history of adrenal cortical carcinoma: a clinicopathologic study of 42 patients. Cancer 1981;47(9):2153–2161.CrossRefPubMed Didolkar MS, Bescher RA, Elias EG, Moore RH. Natural history of adrenal cortical carcinoma: a clinicopathologic study of 42 patients. Cancer 1981;47(9):2153–2161.CrossRefPubMed
6.
Zurück zum Zitat Wanis KN, Kanthan R. Diagnostic and prognostic features in adrenocortical carcinoma: a single institution case series and review of the literature. World Journal of Surgical Oncology 2015;13(1):117.PubMedCentralCrossRefPubMed Wanis KN, Kanthan R. Diagnostic and prognostic features in adrenocortical carcinoma: a single institution case series and review of the literature. World Journal of Surgical Oncology 2015;13(1):117.PubMedCentralCrossRefPubMed
7.
Zurück zum Zitat Miller BS, Gauger PG, Hammer GD, Doherty GM. Resection of adrenocortical carcinoma is less complete and local recurrence occurs sooner and more often after laparoscopic adrenalectomy than after open adrenalectomy. Surgery 2012;152(6):1150–1157.CrossRefPubMed Miller BS, Gauger PG, Hammer GD, Doherty GM. Resection of adrenocortical carcinoma is less complete and local recurrence occurs sooner and more often after laparoscopic adrenalectomy than after open adrenalectomy. Surgery 2012;152(6):1150–1157.CrossRefPubMed
8.
Zurück zum Zitat Donatini G, Caiazzo R, Do Cao C, Aubert S, Zerrweck C, El-Kathib Z, Gauthier T, Leteurtre E, Wemeau JL, Vantyghem MC, Carnaille B, Pattou F. Long-term survival after adrenalectomy for stage I/II adrenocortical carcinoma (ACC): a retrospective comparative cohort study of laparoscopic versus open approach. Annals of Surgical Oncology 2014;21(1):284–291.CrossRefPubMed Donatini G, Caiazzo R, Do Cao C, Aubert S, Zerrweck C, El-Kathib Z, Gauthier T, Leteurtre E, Wemeau JL, Vantyghem MC, Carnaille B, Pattou F. Long-term survival after adrenalectomy for stage I/II adrenocortical carcinoma (ACC): a retrospective comparative cohort study of laparoscopic versus open approach. Annals of Surgical Oncology 2014;21(1):284–291.CrossRefPubMed
9.
Zurück zum Zitat Cooper AB, Habra MA, Grubbs EG, Bednarski BK, Ying AK, Perrier ND, Lee JE, Aloia TA. Does laparoscopic adrenalectomy jeopardize oncologic outcomes for patients with adrenocortical carcinoma? Surgical Endoscopy 2013;27(11):4026–4032.CrossRefPubMed Cooper AB, Habra MA, Grubbs EG, Bednarski BK, Ying AK, Perrier ND, Lee JE, Aloia TA. Does laparoscopic adrenalectomy jeopardize oncologic outcomes for patients with adrenocortical carcinoma? Surgical Endoscopy 2013;27(11):4026–4032.CrossRefPubMed
10.
Zurück zum Zitat Gratian L, Pura J, Dinan M, Reed S, Scheri R, Roman S, Sosa JA. Treatment patterns and outcomes for patients with adrenocortical carcinoma associated with hospital case volume in the United States. Annals of Surgical Oncology 2014;21(11):3509–3514.PubMedCentralCrossRefPubMed Gratian L, Pura J, Dinan M, Reed S, Scheri R, Roman S, Sosa JA. Treatment patterns and outcomes for patients with adrenocortical carcinoma associated with hospital case volume in the United States. Annals of Surgical Oncology 2014;21(11):3509–3514.PubMedCentralCrossRefPubMed
11.
Zurück zum Zitat Mihai R. Diagnosis, treatment and outcome of adrenocortical cancer. The British Journal of Surgery 2015;102(4):291–306.CrossRefPubMed Mihai R. Diagnosis, treatment and outcome of adrenocortical cancer. The British Journal of Surgery 2015;102(4):291–306.CrossRefPubMed
12.
Zurück zum Zitat Przytulska J, Rogala N, Bednarek-Tupikowska G. Current and emerging therapies for adrenocortical carcinoma—review. Advances in Clinical and Experimental Medicine: Official Organ Wroclaw Medical University 2015;24(2):185–193.CrossRef Przytulska J, Rogala N, Bednarek-Tupikowska G. Current and emerging therapies for adrenocortical carcinoma—review. Advances in Clinical and Experimental Medicine: Official Organ Wroclaw Medical University 2015;24(2):185–193.CrossRef
13.
Zurück zum Zitat Saade N, Sadler C, Goldfarb M. Impact of regional lymph node dissection on disease specific survival in adrenal cortical carcinoma. Hormone and Metabolic Research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 2015 Saade N, Sadler C, Goldfarb M. Impact of regional lymph node dissection on disease specific survival in adrenal cortical carcinoma. Hormone and Metabolic Research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 2015
14.
Zurück zum Zitat Dimick JB, Ghaferi AA. Hospital readmission as a quality measure in surgery. JAMA 2015;313(5):512–513.CrossRefPubMed Dimick JB, Ghaferi AA. Hospital readmission as a quality measure in surgery. JAMA 2015;313(5):512–513.CrossRefPubMed
15.
Zurück zum Zitat Merkow RP, Ju MH, Chung JW, Hall BL, Cohen ME, Williams MV, Tsai TC, Ko CY, Bilimoria KY. Underlying reasons associated with hospital readmission following surgery in the United States. JAMA 2015;313(5):483–495.CrossRefPubMed Merkow RP, Ju MH, Chung JW, Hall BL, Cohen ME, Williams MV, Tsai TC, Ko CY, Bilimoria KY. Underlying reasons associated with hospital readmission following surgery in the United States. JAMA 2015;313(5):483–495.CrossRefPubMed
16.
Zurück zum Zitat Tsai TC, Joynt KE, Orav EJ, Gawande AA, Jha AK. Variation in surgical-readmission rates and quality of hospital care. The New England Journal of Medicine 2013;369(12):1134–1142.PubMedCentralCrossRefPubMed Tsai TC, Joynt KE, Orav EJ, Gawande AA, Jha AK. Variation in surgical-readmission rates and quality of hospital care. The New England Journal of Medicine 2013;369(12):1134–1142.PubMedCentralCrossRefPubMed
17.
Zurück zum Zitat Tsai TC, Orav EJ, Jha AK. Patient satisfaction and quality of surgical care in US hospitals. Annals of Surgery 2015;261(1):2–8.CrossRefPubMed Tsai TC, Orav EJ, Jha AK. Patient satisfaction and quality of surgical care in US hospitals. Annals of Surgery 2015;261(1):2–8.CrossRefPubMed
18.
Zurück zum Zitat Coley KC, Williams BA, DaPos SV, Chen C, Smith RB. Retrospective evaluation of unanticipated admissions and readmissions after same day surgery and associated costs. Journal of Clinical Anesthesia 2002;14(5):349–353.CrossRefPubMed Coley KC, Williams BA, DaPos SV, Chen C, Smith RB. Retrospective evaluation of unanticipated admissions and readmissions after same day surgery and associated costs. Journal of Clinical Anesthesia 2002;14(5):349–353.CrossRefPubMed
19.
Zurück zum Zitat Autorino R, Zargar H, Butler S, Laydner H, Kaouk JH. Incidence and risk factors for 30-day readmission in patients undergoing nephrectomy procedures: a contemporary analysis of 5276 cases from the national surgical quality improvement program database. Urology 2015;85(4):843–849.CrossRefPubMed Autorino R, Zargar H, Butler S, Laydner H, Kaouk JH. Incidence and risk factors for 30-day readmission in patients undergoing nephrectomy procedures: a contemporary analysis of 5276 cases from the national surgical quality improvement program database. Urology 2015;85(4):843–849.CrossRefPubMed
20.
Zurück zum Zitat Lucas DJ, Haider A, Haut E, Dodson R, Wolfgang CL, Ahuja N, Sweeney J, Pawlik TM. Assessing readmission after general, vascular, and thoracic surgery using ACS-NSQIP. Annals of Surgery 2013;258(3):430–439.PubMedCentralCrossRefPubMed Lucas DJ, Haider A, Haut E, Dodson R, Wolfgang CL, Ahuja N, Sweeney J, Pawlik TM. Assessing readmission after general, vascular, and thoracic surgery using ACS-NSQIP. Annals of Surgery 2013;258(3):430–439.PubMedCentralCrossRefPubMed
21.
Zurück zum Zitat Mullen MG, LaPar DJ, Daniel SK, Turrentine FE, Hanks JB, Smith PW. Risk factors for 30-day hospital readmission after thyroidectomy and parathyroidectomy in the United States: An analysis of National Surgical Quality Improvement Program outcomes. Surgery 2014;156(6):1423–1430; discussion 1430–1421. Mullen MG, LaPar DJ, Daniel SK, Turrentine FE, Hanks JB, Smith PW. Risk factors for 30-day hospital readmission after thyroidectomy and parathyroidectomy in the United States: An analysis of National Surgical Quality Improvement Program outcomes. Surgery 2014;156(6):1423–1430; discussion 1430–1421.
22.
Zurück zum Zitat Pugely AJ, Callaghan JJ, Martin CT, Cram P, Gao Y. Incidence of and risk factors for 30-day readmission following elective primary total joint arthroplasty: analysis from the ACS-NSQIP. The Journal of Arthroplasty 2013;28(9):1499–1504.CrossRefPubMed Pugely AJ, Callaghan JJ, Martin CT, Cram P, Gao Y. Incidence of and risk factors for 30-day readmission following elective primary total joint arthroplasty: analysis from the ACS-NSQIP. The Journal of Arthroplasty 2013;28(9):1499–1504.CrossRefPubMed
23.
Zurück zum Zitat Zhuang CL, Wang SL, Huang DD, Pang WY, Lou N, Chen BC, Chen XL, Yu Z, Shen X. Risk factors for hospital readmission after radical gastrectomy for gastric cancer: a prospective study. PloS ONE 2015;10(4):e0125572.PubMedCentralCrossRefPubMed Zhuang CL, Wang SL, Huang DD, Pang WY, Lou N, Chen BC, Chen XL, Yu Z, Shen X. Risk factors for hospital readmission after radical gastrectomy for gastric cancer: a prospective study. PloS ONE 2015;10(4):e0125572.PubMedCentralCrossRefPubMed
24.
Zurück zum Zitat Ahmad R, Schmidt BH, Rattner DW, Mullen JT. Factors influencing readmission after curative gastrectomy for gastric cancer. Journal of the American College of Surgeons 2014;218(6):1215–1222.CrossRefPubMed Ahmad R, Schmidt BH, Rattner DW, Mullen JT. Factors influencing readmission after curative gastrectomy for gastric cancer. Journal of the American College of Surgeons 2014;218(6):1215–1222.CrossRefPubMed
25.
Zurück zum Zitat Spolverato G, Maqsood H, Vitale A, Alexandrescu S, Marques HP, Aldrighetti L, Gamblin TC, Pulitano C, Bauer TW, Shen F, Poultsides G, Maithel S, Marsh JW, Pawlik TM. Readmission after liver resection for intrahepatic cholangiocarcinoma: a multi-institutional analysis. Journal of Gastrointestinal Surgery: Official Journal of the Society for Surgery of the Alimentary Tract 2015 Spolverato G, Maqsood H, Vitale A, Alexandrescu S, Marques HP, Aldrighetti L, Gamblin TC, Pulitano C, Bauer TW, Shen F, Poultsides G, Maithel S, Marsh JW, Pawlik TM. Readmission after liver resection for intrahepatic cholangiocarcinoma: a multi-institutional analysis. Journal of Gastrointestinal Surgery: Official Journal of the Society for Surgery of the Alimentary Tract 2015
26.
Zurück zum Zitat Schneider EB, Hyder O, Wolfgang CL, Hirose K, Choti MA, Makary MA, Herman JM, Cameron JL, Pawlik TM. Patient readmission and mortality after surgery for hepato-pancreato-biliary malignancies. Journal of the American College of Surgeons 2012;215(5):607–615.PubMedCentralCrossRefPubMed Schneider EB, Hyder O, Wolfgang CL, Hirose K, Choti MA, Makary MA, Herman JM, Cameron JL, Pawlik TM. Patient readmission and mortality after surgery for hepato-pancreato-biliary malignancies. Journal of the American College of Surgeons 2012;215(5):607–615.PubMedCentralCrossRefPubMed
27.
Zurück zum Zitat Kimbrough CW, Agle SC, Scoggins CR, Martin RC, Marvin MR, Davis EG, McMasters KM, Jones CM. Factors predictive of readmission after hepatic resection for hepatocellular carcinoma. Surgery 2014;156(4):1039–1046.CrossRefPubMed Kimbrough CW, Agle SC, Scoggins CR, Martin RC, Marvin MR, Davis EG, McMasters KM, Jones CM. Factors predictive of readmission after hepatic resection for hepatocellular carcinoma. Surgery 2014;156(4):1039–1046.CrossRefPubMed
28.
Zurück zum Zitat Jeong O, Kyu Park Y, Ran Jung M, Yeop Ryu S. Analysis of 30-day postdischarge morbidity and readmission after radical gastrectomy for gastric carcinoma: a single-center study of 2107 patients with prospective data. Medicine 2015;94(11):e259.PubMedCentralCrossRefPubMed Jeong O, Kyu Park Y, Ran Jung M, Yeop Ryu S. Analysis of 30-day postdischarge morbidity and readmission after radical gastrectomy for gastric carcinoma: a single-center study of 2107 patients with prospective data. Medicine 2015;94(11):e259.PubMedCentralCrossRefPubMed
29.
Zurück zum Zitat Hyder O, Dodson RM, Nathan H, Schneider EB, Weiss MJ, Cameron JL, Choti MA, Makary MA, Hirose K, Wolfgang CL, Herman JM, Pawlik TM. Influence of patient, physician, and hospital factors on 30-day readmission following pancreatoduodenectomy in the United States. JAMA Surgery 2013;148(12):1095–1102.PubMedCentralCrossRefPubMed Hyder O, Dodson RM, Nathan H, Schneider EB, Weiss MJ, Cameron JL, Choti MA, Makary MA, Hirose K, Wolfgang CL, Herman JM, Pawlik TM. Influence of patient, physician, and hospital factors on 30-day readmission following pancreatoduodenectomy in the United States. JAMA Surgery 2013;148(12):1095–1102.PubMedCentralCrossRefPubMed
30.
Zurück zum Zitat Ahmad SA, Edwards MJ, Sutton JM, Grewal SS, Hanseman DJ, Maithel SK, Patel SH, Bentram DJ, Weber SM, Cho CS, Winslow ER, Scoggins CR, Martin RC, Kim HJ, Baker JJ, Merchant NB, Parikh AA, Kooby DA. Factors influencing readmission after pancreaticoduodenectomy: a multi-institutional study of 1302 patients. Annals of Surgery 2012;256(3):529–537.CrossRefPubMed Ahmad SA, Edwards MJ, Sutton JM, Grewal SS, Hanseman DJ, Maithel SK, Patel SH, Bentram DJ, Weber SM, Cho CS, Winslow ER, Scoggins CR, Martin RC, Kim HJ, Baker JJ, Merchant NB, Parikh AA, Kooby DA. Factors influencing readmission after pancreaticoduodenectomy: a multi-institutional study of 1302 patients. Annals of Surgery 2012;256(3):529–537.CrossRefPubMed
31.
Zurück zum Zitat Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Annals of Surgery 2004;240(2):205–213.PubMedCentralCrossRefPubMed Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Annals of Surgery 2004;240(2):205–213.PubMedCentralCrossRefPubMed
32.
Zurück zum Zitat Abdel-Aziz TE, Rajeev P, Sadler G, Weaver A, Mihai R. Risk of adrenocortical carcinoma in adrenal tumours greater than 8 cm. World Journal of Surgery 2015;39(5):1268–1273.CrossRefPubMed Abdel-Aziz TE, Rajeev P, Sadler G, Weaver A, Mihai R. Risk of adrenocortical carcinoma in adrenal tumours greater than 8 cm. World Journal of Surgery 2015;39(5):1268–1273.CrossRefPubMed
33.
Zurück zum Zitat Sathiyakumar V, Molina CS, Thakore RV, Obremskey WT, Sethi MK. ASA score as a predictor of 30-day perioperative readmission in patients with orthopaedic trauma injuries: an NSQIP analysis. Journal of Orthopaedic Trauma 2015;29(3):e127–132.CrossRefPubMed Sathiyakumar V, Molina CS, Thakore RV, Obremskey WT, Sethi MK. ASA score as a predictor of 30-day perioperative readmission in patients with orthopaedic trauma injuries: an NSQIP analysis. Journal of Orthopaedic Trauma 2015;29(3):e127–132.CrossRefPubMed
34.
Zurück zum Zitat Schaeffer JF, Scott DJ, Godin JA, Attarian DE, Wellman SS, Mather RC, 3rd. The Association of ASA Class on Total Knee and Total Hip Arthroplasty Readmission Rates in an Academic Hospital. The Journal of Arthroplasty 2015;30(5):723–727.CrossRefPubMed Schaeffer JF, Scott DJ, Godin JA, Attarian DE, Wellman SS, Mather RC, 3rd. The Association of ASA Class on Total Knee and Total Hip Arthroplasty Readmission Rates in an Academic Hospital. The Journal of Arthroplasty 2015;30(5):723–727.CrossRefPubMed
35.
Zurück zum Zitat Leow JJ, Gandaglia G, Sood A, Ruhotina N, Klett DE, Sammon JD, Schmid M, Sun M, Chang SL, Kibel AS, Trinh QD. Readmissions after major urologic cancer surgery. The Canadian Journal of Urology 2014;21(6):7537–7546.PubMed Leow JJ, Gandaglia G, Sood A, Ruhotina N, Klett DE, Sammon JD, Schmid M, Sun M, Chang SL, Kibel AS, Trinh QD. Readmissions after major urologic cancer surgery. The Canadian Journal of Urology 2014;21(6):7537–7546.PubMed
36.
Zurück zum Zitat Granda-Cameron C, Behta M, Hovinga M, Rundio A, Mintzer D. Risk factors associated with unplanned hospital readmissions in adults with cancer. Oncology Nursing Forum 2015;42(3):E257–268.PubMed Granda-Cameron C, Behta M, Hovinga M, Rundio A, Mintzer D. Risk factors associated with unplanned hospital readmissions in adults with cancer. Oncology Nursing Forum 2015;42(3):E257–268.PubMed
37.
Zurück zum Zitat Schairer WW, Carrer A, Sing DC, Chou D, Mummaneni PV, Hu SS, Berven SH, Burch S, Tay B, Deviren V, Ames C. Hospital readmission rates after surgical treatment of primary and metastatic tumors of the spine. Spine 2014;39(21):1801–1808.CrossRefPubMed Schairer WW, Carrer A, Sing DC, Chou D, Mummaneni PV, Hu SS, Berven SH, Burch S, Tay B, Deviren V, Ames C. Hospital readmission rates after surgical treatment of primary and metastatic tumors of the spine. Spine 2014;39(21):1801–1808.CrossRefPubMed
Metadaten
Titel
Incidence and Risk Factors Associated with Readmission After Surgical Treatment for Adrenocortical Carcinoma
verfasst von
Javier Valero-Elizondo
Yuhree Kim
Jason D. Prescott
Georgios A. Margonis
Thuy B. Tran
Lauren M. Postlewait
Shishir K. Maithel
Tracy S. Wang
Jason A. Glenn
Ioannis Hatzaras
Rivfka Shenoy
John E. Phay
Kara Keplinger
Ryan C. Fields
Linda X. Jin
Sharon M. Weber
Ahmed Salem
Jason K. Sicklick
Shady Gad
Adam C. Yopp
John C. Mansour
Quan-Yang Duh
Natalie Seiser
Carmen C. Solorzano
Colleen M. Kiernan
Konstantinos I. Votanopoulos
Edward A. Levine
George A. Poultsides
Timothy M. Pawlik
Publikationsdatum
01.12.2015
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Surgery / Ausgabe 12/2015
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-015-2917-x

Weitere Artikel der Ausgabe 12/2015

Journal of Gastrointestinal Surgery 12/2015 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.